Cécile Guillemet

3.4k total citations
64 papers, 1.4k citations indexed

About

Cécile Guillemet is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Cécile Guillemet has authored 64 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 32 papers in Oncology and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Cécile Guillemet's work include Sarcoma Diagnosis and Treatment (30 papers), Ovarian cancer diagnosis and treatment (10 papers) and Vascular Tumors and Angiosarcomas (9 papers). Cécile Guillemet is often cited by papers focused on Sarcoma Diagnosis and Treatment (30 papers), Ovarian cancer diagnosis and treatment (10 papers) and Vascular Tumors and Angiosarcomas (9 papers). Cécile Guillemet collaborates with scholars based in France, Luxembourg and Austria. Cécile Guillemet's co-authors include Jean‐Yves Blay, Florence Duffaud, Didier Cupissol, Isabelle Ray‐Coquard, Nicolas Penel, Emmanuelle Bompas, María Rios, Sylvie Chabaud, David Pérol and Christine Chevreau and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Cécile Guillemet

59 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cécile Guillemet France	17	964	507	387	291	280	64	1.4k
Olivier Collard France	16	1.1k 1.1×	681 1.3×	440 1.1×	206 0.7×	116 0.4×	67	1.6k
Palma Dileo United Kingdom	18	1.6k 1.7×	850 1.7×	499 1.3×	400 1.4×	179 0.6×	52	2.0k
Binh Bui Nguyen France	12	1.1k 1.1×	658 1.3×	275 0.7×	196 0.7×	104 0.4×	49	1.3k
Claudia Valverde Spain	20	688 0.7×	391 0.8×	152 0.4×	128 0.4×	283 1.0×	84	1.1k
Andrea Marrari Italy	20	1.1k 1.1×	519 1.0×	749 1.9×	282 1.0×	65 0.2×	57	1.5k
M. Ouali France	19	1.4k 1.5×	957 1.9×	350 0.9×	338 1.2×	59 0.2×	46	1.8k
Nicole H. Moraco United States	12	1.1k 1.1×	713 1.4×	227 0.6×	190 0.7×	44 0.2×	14	1.3k
Masanori Shiraki United States	11	1.2k 1.2×	686 1.4×	540 1.4×	365 1.3×	56 0.2×	14	1.5k
Priscilla Merriam United States	13	833 0.9×	686 1.4×	107 0.3×	170 0.6×	72 0.3×	28	1.2k
Federica Bertolini Italy	28	946 1.0×	1.2k 2.3×	122 0.3×	210 0.7×	297 1.1×	120	2.2k

Countries citing papers authored by Cécile Guillemet

Since Specialization

Citations

This map shows the geographic impact of Cécile Guillemet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cécile Guillemet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cécile Guillemet more than expected).

Fields of papers citing papers by Cécile Guillemet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cécile Guillemet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cécile Guillemet. The network helps show where Cécile Guillemet may publish in the future.

Co-authorship network of co-authors of Cécile Guillemet

This figure shows the co-authorship network connecting the top 25 collaborators of Cécile Guillemet. A scholar is included among the top collaborators of Cécile Guillemet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cécile Guillemet. Cécile Guillemet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zemmour, Christophe, Manuel Rodrigues, Isabelle Ray‐Coquard, et al.. (2025). PARP inhibitors as maintenance therapy in ovarian cancer after platinum-sensitive recurrence: real-world experience from the Unicancer network. The Oncologist. 30(5).

Chevrier, Marion, Jean‐Sébastien Frenel, Frédéric Guyon, et al.. (2025). Role of platinum-free interval (PFI) and maintenance therapies in recurrent ovarian cancer to explain survival. An analysis from the French real-world ESME Ovarian Database. Gynecologic Oncology. 201. 17–25.

Pautier, Patricia, Antoîne Italiano, Sophie Piperno‐Neumann, et al.. (2024). Doxorubicin–Trabectedin with Trabectedin Maintenance in Leiomyosarcoma. New England Journal of Medicine. 391(9). 789–799. 29 indexed citations

Penel, Nicolas, Sylvie Bonvalot, Marie‐Cécile Le Deley, et al.. (2023). Pain in desmoid‐type fibromatosis: Prevalence, determinants and prognosis value. International Journal of Cancer. 153(2). 407–416. 8 indexed citations

Beaussire, Ludivine, Marianne Leheurteur, Cécile Guillemet, et al.. (2023). Clinical relevance of circulating ESR1 mutations during endocrine therapy for advanced hormone-dependent endometrial carcinoma. BMC Cancer. 23(1). 1061–1061. 5 indexed citations

Penel, Nicolas, Sylvie Bonvalot, Alexandra Meurgey, et al.. (2022). Lack of Prognostic Value of CTNNB1 Mutation Profile in Desmoid-Type Fibromatosis. Clinical Cancer Research. 28(18). 4105–4111. 13 indexed citations

Chevreau, Christine, Caroline Delmas, Jean‐Yves Blay, et al.. (2020). Pharmacogenetic Study of Trabectedin-Induced Severe Hepatotoxicity in Patients with Advanced Soft Tissue Sarcoma. Cancers. 12(12). 3647–3647. 3 indexed citations

Colombo, Nicoletta, Justine Gantzer, Beyhan Ataseven, et al.. (2020). 812MO Maintenance olaparib + bevacizumab (bev) in patients (pts) with newly diagnosed advanced high-grade ovarian cancer (HGOC): RECIST and/or CA-125 objective response rate (ORR) in the phase III PAOLA-1 trial. Annals of Oncology. 31. S614–S614. 2 indexed citations

Lefeuvre, Claudia, Anne Floquet, Dan Chaltiel, et al.. (2020). Effect of high-dose chemotherapy with autologous stem cell rescue (HDC-aSCR) on outcome in ovarian small-cell carcinoma, hypercalcemic type (SCCOHT): Prospective series from the French Rare Gynecologic Malignant Tumors Network (TMRG).. Journal of Clinical Oncology. 38(15_suppl). 6023–6023. 1 indexed citations

10.

Marec‐Bérard, Perrine, Valérie Laurence, Bob‐Valéry Occéan, et al.. (2019). Methotrexate–Etoposide–Ifosfamide Compared with Doxorubicin–Cisplatin–Ifosfamide Chemotherapy in Osteosarcoma Treatment, Patients Aged 18–25 Years. Journal of Adolescent and Young Adult Oncology. 9(2). 172–182. 12 indexed citations

11.

Cesne, Axel Le, Jean‐Yves Blay, Didier Cupissol, et al.. (2018). Results of a prospective randomized phase III T-SAR trial comparing trabectedin (T) vs best supportive care (BSC) in patients with pretreated advanced soft tissue sarcoma (ASTS): A French Sarcoma Group (FSG) trial.. Journal of Clinical Oncology. 36(15_suppl). 11508–11508. 6 indexed citations

12.

Beaussire, Ludivine, Anne Perdrix, David Sefrioui, et al.. (2017). Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients. Annals of Oncology. 28. v58–v58. 3 indexed citations

13.

Cesne, Axel Le, Jean‐Yves Blay, Didier Cupissol, et al.. (2016). Results of a prospective randomized phase III T-SAR trial comparing trabectedin vs best supportive care (BSC) in patients with pretreated advanced soft tissue sarcoma (ASTS). Annals of Oncology. 27. vi483–vi483. 3 indexed citations

14.

Cesne, Axel Le, Isabelle Ray‐Coquard, Florence Duffaud, et al.. (2015). Trabectedin in patients with advanced soft tissue sarcoma: A retrospective national analysis of the French Sarcoma Group. European Journal of Cancer. 51(6). 742–750. 80 indexed citations

15.

Pautier, P., Anne Floquet, Laurence Gladieff, et al.. (2011). A Randomized Clinical Trial of Adjuvant Chemotherapy with Doxorubicin, Ifosfamide, and Cisplatin in Localized Uterine Sarcomas. Results On 81 Randomized Patients. European Journal of Cancer. 47. 15–15. 1 indexed citations

16.

Pautier, P., Anne Floquet, Laurence Gladieff, et al.. (2011). A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin in localized uterine sarcomas: Results from 81 randomized patients.. Journal of Clinical Oncology. 29(15_suppl). 10022–10022. 3 indexed citations

17.

Isambert, Nicolás, I. L. Ray-Coquard, Binh Bui Nguyen, et al.. (2011). Management and outcomes for primary cardiac sarcomas (PCS): A retrospective study of the French Sarcoma Group (FSG).. Journal of Clinical Oncology. 29(15_suppl). 10093–10093. 2 indexed citations

18.

Kurtz, J.E., Anne‐Claire Hardy‐Bessard, Marion Deslandres, et al.. (2009). Cetuximab, topotecan and cisplatin for the treatment of advanced cervical cancer: A phase II GINECO trial. Gynecologic Oncology. 113(1). 16–20. 62 indexed citations

19.

Müller, Marie, Pierre‐François Dupré, B. Lucas, et al.. (2007). Le carcinosarcome ovarien. Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément. 36(4). 399–402. 8 indexed citations

20.

Fayette, Jérôme, Armelle Dufresne, Nicolas Penel, et al.. (2007). Imatinib for the treatment of aggressive fibromatosis/desmoid tumors (AF/DT) failing local treatment: updated outcome and predictive factors for progression free survival. A FNCLCC French Sarcoma Group-GETO study. Journal of Clinical Oncology. 25(18_suppl). 10062–10062. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact